Diabetes Medication recalls

The FDA has published 242 recalls involving diabetes medication since 2012. The latest was reported on 9 Sep 2026. Most were for sterility. Novo Nordisk has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls242since 2012

Last 12 months33reported

Class I167% of total

Ongoing101latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 2 0Feb 0 2 1May 0 8 13Aug 3 3 7Nov 0 2 0Feb 6 1 1May 0 1 11Aug 1 0

Severity split

Class I 16 7%Class II 215 89%Class III 11 5%

Why diabetes medication is recalled

Companies

Brands

Metformin Hydrochloride156%
Glimepiride83%
Metformin Hydrochloride Extended Release73%
Synjardy31%
Riomet31%
Fiasp31%
Tresiba31%
Pioglitazone21%

By year

20262310%
20253916%
2024125%
2023229%
2022167%
20213012%
20204418%
201921%
2018125%
201773%

Ongoing diabetes medication recalls

101 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection/mL) recalledMyxredlin	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 5mg (1mg/mL), Glycine 25 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 4.5mg (0.9 mg/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 9mg (4.5 mg/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 10mg (5mg/mL), Glycine 10 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 20mg (5mg/mL), Glycine 20 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide

All diabetes medication recalls, newest first

242 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection/mL) recalledMyxredlin	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 5mg (1mg/mL), Glycine 25 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 4.5mg (0.9 mg/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 9mg (4.5 mg/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 10mg (5mg/mL), Glycine 10 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 20mg (5mg/mL), Glycine 20 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 0.9mg (0.9 mg/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 6.75mg (4.5 mg/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 2.5mg (1mg/mL), Glycine 12.5 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 2.25MG (0.9 mg/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 12.5MG (2.5MG/mL) Sterile Multi-Dose Vial recalled	Apollo Care	Particulate Matter	Nationwide
19 Aug 2026Drug	CLASS II	Semaglutide 7.5mg (5mg/mL), Glycine 7.5 mg recalled by Apollo Care	Apollo Care	Particulate Matter	Nationwide
8 Jul 2026Drug	CLASS II	Synjardy XR Tablets (empagliflozin recalled by Boehringer Ingelheim	Boehringer Ingelheim Pharmaceuticals	Manufacturing (CGMP) Deviations	OH
27 May 2026Drug	CLASS II	Liraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutide	Lupin Pharmaceuticals	Particulate Matter	Nationwide
22 Apr 2026Drug	CLASS II	Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg recalled	Payless Compounders	Sterility	OR
11 Mar 2026Drug	CLASS II	Semaglutide, For Rx compounding use only recalled	Harbin Jixianglong Biotech	Manufacturing (CGMP) Deviations	Nationwide
11 Mar 2026Drug	CLASS II	Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial recalled	New Life Pharma	Sterility	OH
11 Mar 2026Drug	CLASS II	Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial recalled	New Life Pharma	Sterility	OH
11 Mar 2026Drug	CLASS II	Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial recalled	New Life Pharma	Sterility	OH
11 Mar 2026Drug	CLASS II	Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial recalled	New Life Pharma	Sterility	OH
11 Mar 2026Drug	CLASS II	Semaglutide, For Rx compounding use only recalled	Harbin Jixianglong Biotech	Manufacturing (CGMP) Deviations	Nationwide
7 Jan 2026Drug	CLASS II	Wegovy (semaglutide) Injection, 0.5 mg/-Dose Prefilled Pens recalled	Novo Nordisk	Particulate Matter	Nationwide
7 Jan 2026Drug	CLASS II	Wegovy (semaglutide) Injection, 1 mg/-Dose Prefilled Pens recalled	Novo Nordisk	Particulate Matter	Nationwide
5 Nov 2025Drug	CLASS II	Semaglutide Injection, 5 mg/ (2.5 mg/mL) Multidose Vial recalled	ProRx	Sterility	TX, UT
5 Nov 2025Drug	CLASS II	Semaglutide Injection (2.5 mg/mL) Multidose Vial recalled by ProRx	ProRx	Sterility	TX, UT
5 Nov 2025Drug	CLASS II	Tirzepatide Injection, 27 mg/ (9 mg/mL) Multidose Vial recalled by ProRx	ProRx	Sterility	TX, UT
5 Nov 2025Drug	CLASS II	Semaglutide Injection, 8mg/ (2.5 mg/mL) Multidose Vial recalled by ProRx	ProRx	Sterility	TX, UT
5 Nov 2025Drug	CLASS II	Semaglutide Injection, 2.5mg/ (2.5 mg/mL) Multidose Vial recalled	ProRx	Sterility	TX, UT
5 Nov 2025Drug	CLASS II	Semaglutide Injection, 6mg/ (2.5 mg/mL) Multidose Vial recalled by ProRx	ProRx	Sterility	TX, UT
5 Nov 2025Drug	CLASS II	Semaglutide Injection, 10 mg/ (2.5 mg/mL) Multidose Vial recalled	ProRx	Sterility	TX, UT

Should you stop taking Diabetes Medication?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.

Alert me about Diabetes Medication

One email the day a new recall is posted for Diabetes Medication. Unsubscribe any time.

At a glance

Latest recall: 9 Sep 2026
First on record: 8 Aug 2012
Class I share: 7%
Ongoing: 101

Drug classes

Injectable & IV Drugs 4,627Pain Medication 1,518Creams, Ointments & Gels 930Blood Pressure Medication 837Compounded Drugs 721Eye Drops 600Hormones & Birth Control 495Antibiotics 492Allergy Medication 348Stomach & Acid Reflux Medication 313Cold & Cough Medicine 312Diabetes Medication 242

Recall classes

CLASS ISerious harm or death possible.

CLASS IITemporary or reversible harm.

CLASS IIIUnlikely to cause harm.